These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 9477122)
1. Mobilisation and reinfusion of Philadelphia negative peripheral blood mononuclear cells in chronic myeloid leukaemia with hydroxyurea and G-CSF. Johnson RJ; Smith GM Leuk Lymphoma; 1997 Nov; 27(5-6):401-15. PubMed ID: 9477122 [TBL] [Abstract][Full Text] [Related]
2. Autologous stem cell transplantation in chronic myeloid leukaemia using Philadelphia chromosome negative blood progenitors mobilised with hydroxyurea and G-CSF. Pratt G; Johnson RJ; Rawstron AC; Barnard DL; Morgan GJ; Smith GM Bone Marrow Transplant; 1998 Mar; 21(5):455-60. PubMed ID: 9535037 [TBL] [Abstract][Full Text] [Related]
3. Collection of Philadelphia-negative stem cells using recombinant human granulocyte colony-stimulating factor in chronic myeloid leukemia patients treated with alpha-interferon. Hernández-Boluda JC; Carreras E; Cervantes F; Marín P; Arellano-Rodrigo E; Rovira M; Solé F; Lloveras E; Espinet B; Ocejo A; Montserrat E Haematologica; 2002 Jan; 87(1):17-22. PubMed ID: 11801461 [TBL] [Abstract][Full Text] [Related]
4. High-dose hydroxyurea plus G-CSF mobilize BCR-ABL-negative progenitor cells (CFC, LTC-IC) into the blood of newly diagnosed CML patients at any time of hematopoietic regeneration. Petzer AL; Hochenburger E; Haun M; Duba HCh; Grünewald K; Hoflehner E; Sill H; Linkesch W; Gastl G; Gunsilius E J Hematother Stem Cell Res; 2002 Apr; 11(2):293-300. PubMed ID: 11983100 [TBL] [Abstract][Full Text] [Related]
5. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells. Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574 [TBL] [Abstract][Full Text] [Related]
6. Mobilization of Philadelphia-negative peripheral blood mononuclear cells in chronic myeloid leukaemia using hydroxyurea and G-CSF (filgrastim). Johnson RJ; Owen RG; Child JA; Morgan GJ; Barnard DL; Dickinson H; Ricketts S; Rawstron A; Evans P; Woodhead V; Major K; Robinson F; Smith GM Br J Haematol; 1996 Jun; 93(4):863-8. PubMed ID: 8703818 [TBL] [Abstract][Full Text] [Related]
7. Emergence of Philadelphia positive chronic myeloid leukaemia during treatment with hydroxyurea for Philadelphia negative essential thrombocythaemia. Wahlin A; Golovleva I Eur J Haematol; 2003 Apr; 70(4):240-1. PubMed ID: 12656748 [TBL] [Abstract][Full Text] [Related]
8. Ph-negative blood progenitor cells (BPCs) can be recruited after chemotherapy and G-CSF during early hemopoietic recovery in patients at diagnosis of CML or pretreated only with hydroxyurea. Carella AM; Frassoni F; Pollicardo N; Pungolino E; Podestà M; Giordano D; Ferrero R; Soracco M; Benvenuto F; Figari O Bone Marrow Transplant; 1994; 14 Suppl 3():S34-7. PubMed ID: 7535152 [No Abstract] [Full Text] [Related]
9. Successful peripheral blood stem cell mobilisation with filgrastim in patients with chronic myeloid leukaemia achieving complete cytogenetic response with imatinib, without increasing disease burden as measured by quantitative real-time PCR. Hui CH; Goh KY; White D; Branford S; Grigg A; Seymour JF; Kwan YL; Walsh S; Hoyt R; Trickett A; Rudzki B; Ma DD; To LB; Hughes TP Leukemia; 2003 May; 17(5):821-8. PubMed ID: 12750692 [TBL] [Abstract][Full Text] [Related]
10. High-dose hydroxyurea and G-CSF to collect Philadelphia-negative cells in chronic myeloid leukemia: preliminary results. Mehta J; Powles R; Singhal S; Swansbury GJ; Millar B; Shepherd V; Bell J; Min T; Cabral S; Treleaven J Leuk Lymphoma; 1996 Sep; 23(1-2):107-11. PubMed ID: 9021692 [TBL] [Abstract][Full Text] [Related]
11. Successful mobilization of Ph-negative blood stem cells with intensive chemotherapy + G-CSF in patients with chronic myelogenous leukemia in first chronic phase. Olsson-Strömberg U; Höglund M; Björkholm M; Braide I; Carlson K; Gahrton G; Grimfors G; Hast R; Lerner R; Linder O; Ljungman P; Löfvenberg E; Malm C; Nilsson PG; Paul C; Rödjer S; Stenke L; Tidefeldt U; Turesson I; Uden AM; Wahlin A; Vilen L; Winqvist I; Zettervall O; Oberg G; Simonsson B Leuk Lymphoma; 2006 Sep; 47(9):1768-73. PubMed ID: 17064986 [TBL] [Abstract][Full Text] [Related]